145 related articles for article (PubMed ID: 29233785)
1. Angiotensin II receptor blocker valsartan ameliorates cardiac fibrosis partly by inhibiting miR-21 expression in diabetic nephropathy mice.
Wang J; Duan L; Gao Y; Zhou S; Liu Y; Wei S; An S; Liu J; Tian L; Wang S
Mol Cell Endocrinol; 2018 Sep; 472():149-158. PubMed ID: 29233785
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of miR-30c promotes renal fibrosis by target CTGF in diabetic nephropathy.
Wang J; Duan L; Guo T; Gao Y; Tian L; Liu J; Wang S; Yang J
J Diabetes Complications; 2016 Apr; 30(3):406-14. PubMed ID: 26775556
[TBL] [Abstract][Full Text] [Related]
3. Effect of miR-21 on renal fibrosis by regulating MMP-9 and TIMP1 in kk-ay diabetic nephropathy mice.
Wang J; Gao Y; Ma M; Li M; Zou D; Yang J; Zhu Z; Zhao X
Cell Biochem Biophys; 2013 Nov; 67(2):537-46. PubMed ID: 23443810
[TBL] [Abstract][Full Text] [Related]
4. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy.
Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK
Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517
[TBL] [Abstract][Full Text] [Related]
5. Serum miR-21 may be a Potential Diagnostic Biomarker for Diabetic Nephropathy.
Wang J; Duan L; Tian L; Liu J; Wang S; Gao Y; Yang J
Exp Clin Endocrinol Diabetes; 2016 Jul; 124(7):417-23. PubMed ID: 26575121
[TBL] [Abstract][Full Text] [Related]
6. Tongxinluo ameliorates renal structure and function by regulating miR-21-induced epithelial-to-mesenchymal transition in diabetic nephropathy.
Wang JY; Gao YB; Zhang N; Zou DW; Xu LP; Zhu ZY; Li JY; Zhou SN; Cui FQ; Zeng XJ; Geng JG; Yang JK
Am J Physiol Renal Physiol; 2014 Mar; 306(5):F486-95. PubMed ID: 24370587
[TBL] [Abstract][Full Text] [Related]
7. miR-30e targets GLIPR-2 to modulate diabetic nephropathy:
Zhao D; Jia J; Shao H
J Mol Endocrinol; 2017 Aug; 59(2):181-190. PubMed ID: 28733476
[TBL] [Abstract][Full Text] [Related]
8. miR-485 suppresses inflammation and proliferation of mesangial cells in an in vitro model of diabetic nephropathy by targeting NOX5.
Wu J; Lu K; Zhu M; Xie X; Ding Y; Shao X; Chen Y; Liu J; Xu M; Xu Y; Zhou J; Shen X; Zhu C
Biochem Biophys Res Commun; 2020 Jan; 521(4):984-990. PubMed ID: 31727371
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA TUG1 alleviates extracellular matrix accumulation via mediating microRNA-377 targeting of PPARγ in diabetic nephropathy.
Duan LJ; Ding M; Hou LJ; Cui YT; Li CJ; Yu DM
Biochem Biophys Res Commun; 2017 Mar; 484(3):598-604. PubMed ID: 28137588
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Angiotensin-Converting Enzyme Ameliorates Renal Fibrosis by Mitigating DPP-4 Level and Restoring Antifibrotic MicroRNAs.
Srivastava SP; Goodwin JE; Kanasaki K; Koya D
Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32085655
[TBL] [Abstract][Full Text] [Related]
11. High glucose down-regulates microRNA-181a-5p to increase pro-fibrotic gene expression by targeting early growth response factor 1 in HK-2 cells.
Xu P; Guan MP; Bi JG; Wang D; Zheng ZJ; Xue YM
Cell Signal; 2017 Feb; 31():96-104. PubMed ID: 28077323
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-214 exerts a Cardio-protective effect by inhibition of fibrosis.
Dong H; Dong S; Zhang L; Gao X; Lv G; Chen W; Shao S
Anat Rec (Hoboken); 2016 Oct; 299(10):1348-57. PubMed ID: 27357906
[TBL] [Abstract][Full Text] [Related]
13. MiR-22 may Suppress Fibrogenesis by Targeting TGFβR I in Cardiac Fibroblasts.
Hong Y; Cao H; Wang Q; Ye J; Sui L; Feng J; Cai X; Song H; Zhang X; Chen X
Cell Physiol Biochem; 2016; 40(6):1345-1353. PubMed ID: 27997889
[TBL] [Abstract][Full Text] [Related]
14. MiR-30c protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition in db/db mice.
Zhao Y; Yin Z; Li H; Fan J; Yang S; Chen C; Wang DW
Aging Cell; 2017 Apr; 16(2):387-400. PubMed ID: 28127848
[TBL] [Abstract][Full Text] [Related]
15. MiR-455-3p suppresses renal fibrosis through repression of ROCK2 expression in diabetic nephropathy.
Wu J; Liu J; Ding Y; Zhu M; Lu K; Zhou J; Xie X; Xu Y; Shen X; Chen Y; Shao X; Zhu C
Biochem Biophys Res Commun; 2018 Sep; 503(2):977-983. PubMed ID: 29932921
[TBL] [Abstract][Full Text] [Related]
16. The Alcohol Extract of
Yu S; Zhao H; Yang W; Amat R; Peng J; Li Y; Deng K; Mao X; Jiao Y
Biomed Res Int; 2019; 2019():5280514. PubMed ID: 31032350
[TBL] [Abstract][Full Text] [Related]
17. Hyperoside ameliorates glomerulosclerosis in diabetic nephropathy by downregulating miR-21.
Zhang L; He S; Yang F; Yu H; Xie W; Dai Q; Zhang D; Liu X; Zhou S; Zhang K
Can J Physiol Pharmacol; 2016 Dec; 94(12):1249-1256. PubMed ID: 27704873
[TBL] [Abstract][Full Text] [Related]
18. CircRNA_000203 enhances the expression of fibrosis-associated genes by derepressing targets of miR-26b-5p, Col1a2 and CTGF, in cardiac fibroblasts.
Tang CM; Zhang M; Huang L; Hu ZQ; Zhu JN; Xiao Z; Zhang Z; Lin QX; Zheng XL; -Yang M; Wu SL; Cheng JD; Shan ZX
Sci Rep; 2017 Jan; 7():40342. PubMed ID: 28079129
[TBL] [Abstract][Full Text] [Related]
19. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-27a promotes renal tubulointerstitial fibrosis via suppressing PPARγ pathway in diabetic nephropathy.
Hou X; Tian J; Geng J; Li X; Tang X; Zhang J; Bai X
Oncotarget; 2016 Jul; 7(30):47760-47776. PubMed ID: 27351287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
